Clinical Trial Update: A Proof-of-Concept Study to Assess Batoclimab in Participants With Graves' Disease [Phase 2]

View source ↗

Summary

Batoclimab was evaluated in a Phase 2 proof-of-concept study for Graves' disease, and the trial status is reported as completed. The provided snippet does not i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graves Disease

Drugs mentioned

• Batoclimab (batoclimab)

Snippet

Sponsor: Immunovant Sciences GmbH | Conditions: Graves Disease | Phase 2 | Status: COMPLETED